ITRI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Itron is not a clear buy right now for a Beginner investor with a long-term focus and $50,000-$100,000 to deploy. The stock has some constructive support from bullish analyst ratings and a generally favorable long-term theme around grid-edge, electrification, and data-center-driven power demand, but the current setup is mixed: price is below the pivot, moving averages are bearish, and recent earnings guidance was below expectations. Since there is no strong proprietary buy signal today, I would not call this a direct buy at the current pre-market price of 80.89. The better call is to hold and wait for stronger confirmation.
Current pre-market price is 80.89, slightly above the current quoted price of 80.72, with a small pre-market gain of 0.21%. Short-term momentum is weak-to-neutral. RSI_6 at 43.6 is neutral, so the stock is not oversold enough to signal an obvious rebound. MACD histogram is positive at 0.0509 but contracting, which suggests momentum is fading rather than strengthening. The moving-average structure is bearish with SMA_200 > SMA_20 > SMA_5, indicating the broader trend is still under pressure. Key levels: pivot 81.913, resistance 84.526 and 86.14, support 79.3 and 77.686. The stock is trading just above support, so the tape is not broken, but it is not showing a strong breakout trend either.
["Several analysts still keep Buy/Outperform/Overweight-type ratings on the name.", "JPMorgan sees a catalyst-rich environment with data-center contract announcements and increased order volumes helping sentiment.", "Oppenheimer highlighted stronger electrification demand and improving margins.", "Grid-edge technology deployment is said to be on track with no major labor or materials constraints.", "The company may benefit longer term from asset-light transition, improving margins and wallet share."]
["TD Cowen, Roth Capital, and Baird all lowered price targets after Q1 results and weaker Q2 guidance.", "Raymond James resumed coverage with an Underperform rating and argued the stock may be worth materially below current prices.", "Recent news points to an earnings downgrade and expected declines in EPS and revenue.", "Near-term revenue growth is described as more subdued due to complex projects and regulatory dynamics.", "Technical trend remains bearish with moving averages stacked negatively."]
Latest quarter season appears to be Q1 2026. The company beat expectations on a pull-forward basis, but the follow-up Q2 2026 guidance came in below expectations. That implies the latest quarter was not a clean growth acceleration story, even though longer-term operating leverage and margin improvement themes remain intact. The recent earnings-related commentary suggests revenue and EPS trends are softer in the near term rather than strongly expanding.
Recent analyst activity shows a mostly positive but softer tone: Buy/Outperform/Overweight ratings are still being maintained by TD Cowen, Roth Capital, Baird, Oppenheimer, and JPMorgan, but several firms cut price targets after the Q1 print and weaker Q2 outlook. The clearest negative outlier is Raymond James, which resumed with Underperform and argued the stock is meaningfully overvalued versus fair value. Net: Wall Street is still more positive than negative, but the enthusiasm has cooled, with pros citing long-term electrification and margin improvement while cons focus on normalization, slower revenue growth, and valuation pressure.
